Sarilumab Effect on the Pharmacokinetics of Simvastatin

NCT02017639 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: sarilumab SAR153191 (REGN88)
DRUG: simvastatin

Sponsor

Sanofi

Collaborators

[object Object]